Download full report with analyst certification and important disclosures
Nov 2 2021, 16:10 GMT
Foods
ADM to acquire Deerland Probiotics & Enzymes
- Sectors : Foods
- Companies : Givaudan | Kerry Group | Symrise | dsm-firmenich
Ratings
Ratings and price correct at time of issue
| Company | Rating | Date | Previous Rating | Date | Closing Price |
|---|---|---|---|---|---|
| dsm-firmenich | OUTPERFORM | 09/10/20 | Neutral | 13/02/20 | 18870c |
| Givaudan | OUTPERFORM | 24/03/20 | Neutral | 21/06/12 | 442800chf |
| Kerry Group | OUTPERFORM | 30/06/09 | N/A | N/A | 11600c |
| Symrise | OUTPERFORM | 24/03/20 | Neutral | 15/01/19 | 12335c |
DAVY VIEW
The Archer-Daniels-Midland Company (ADM) is set to add another string to its health and wellness bow with the acquisition of Deerland Probiotics & Enzymes. Deerland focuses on providing probiotic and dietary supplements using probiotic, prebiotic and enzyme technology. ADM has joined the ranks of other ingredients names, such as IFF, DSM, Kerry Group, Chr. Hansen and Symrise, with a growing pro-active health platform including microbiome solutions. ADM’s growing Nutrition division reported operating profits of $574m in CY20 – as such, it is becoming a more relevant, value-add ingredients player.
